Related Experiment Video
Updated: May 16, 2026

11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Metabolomics analysis for biomarker discovery: advances and challenges
M S Monteiro1, M Carvalho, M L Bastos
1REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, Porto University, Portugal. mtacf10006@ff.up.pt
Current Medicinal Chemistry
|December 6, 2012
Summary
Metabolomics, the study of all metabolites, offers sensitive and specific biomarker discovery for diseases. Despite challenges, advances enhance its clinical health applications.
Area of Science:
- Biomedical research
- Systems biology
- Analytical chemistry
Background:
- Shift from single-molecule studies to comprehensive 'omics' approaches.
- Metabolomics, the analysis of all metabolites, is a recent but rapidly growing field.
- Metabolites are key players in biological systems; disease disrupts biochemical pathways.
Purpose of the Study:
- To review the characteristics, strengths, limitations, and recent advances in metabolomics.
- To highlight metabolomics' potential as a biomarker discovery tool in clinical and health areas.
- To provide insight into the implementation of metabolomics in healthcare.
Main Methods:
- Comprehensive analysis of all metabolites within a biological system.
- Utilizes advanced analytical techniques for metabolite detection.
- Employs pattern recognition methods for data analysis.
Main Results:
- Metabolomics offers potential advantages in sensitivity and specificity over conventional biomarkers.
- Demonstrated benefits in various clinical areas for disease diagnosis and understanding.
- Identified intrinsic limitations impacting widespread implementation, particularly in biological and experimental measurements.
Conclusions:
- Metabolomics holds significant promise for biomarker discovery and clinical applications.
- Continued advancements in analytical techniques and data analysis are crucial.
- Addressing current limitations is key to realizing the full potential of metabolomics in healthcare.

